30 juni 2009 United Kingdom
Scrip: Diamyd tests preventative diabetes vaccine in high-risk childrenDiamyd has started a Phase II trial to examine whether the company's experimental vaccine, its lead candidate, which is also called Diamyd, is effective as a prophylactic treatment for children at high risk of developing diabetes.
Click here to read the article
Information som presenteras här är inte pressmeddelanden och kan innehålla utdrag ur och länkar till externt publicerat innehåll. Diamyd Medical ansvarar inte för externt publicerat innehåll.